Growth plate chondrocytes are susceptible to apoptosis. Terminally differentiated chondrocytes are deleted via apoptosis, which primes the growth plate to vascular invasion and subsequent bone formation. Whether less differentiated resting zone chondrocytes are subject to the same mechanism that governs the apoptotic pathway of more differentiated growth zone chondrocytes is not known. In our current study, we demonstrated that inorganic phosphate, a key inducer of growth plate chondrocyte apoptosis, also causes apoptosis in resting zone chondrocytes, via a pathway similar to the one in growth zone chondrocytes. Our results demonstrated that the conditions that cause growth plate chondrocyte apoptosis lie in the external environment, instead of the differences in differentiation state.

Keywords:
Apoptosis, Cartilage research, Chondrocytes, Growth plate, Thrombin, Phosphate
1.
Adams, C.S., I.M. Shapiro (2002) The fate of the terminally differentiated chondrocyte: evidence for microenvironmental regulation of chondrocyte apoptosis. Crit Rev Oral Biol Med 13: 465–473.
2.
Gibson, G. (1998) Active role of chondrocyte apoptosis in endochondral ossification. Microsc Res Tech 43: 191–204.
3.
Hatori, M., K.J. Klatte, C.C. Teixeira, I.M. Shapiro (1995) End labeling studies of fragmented DNA in the avian growth plate: evidence of apoptosis in terminally differentiated chondrocytes. J Bone Miner Res 10: 1960–1968.
4.
Howell, D.S., J.C. Pita, J.F. Marquez, R.A. Gatter (1969) Demonstration of macromolecular inhibitors of calcification and nucleational factors in fluid from calcifying sites in cartilage. J Clin Invest 48: 630–641.
5.
Kakuta, S., E.E. Golub, I.M. Shapiro (1985) Morphochemical analysis of phosphorus pools in calcifying cartilage. Calcif Tissue Int 37: 293–299.
6.
Mansfield, K., R. Rajpurohit, I.M. Shapiro (1999) Extracellular phosphate ions cause apoptosis of terminally differentiated epiphyseal chondrocytes. J Cell Physiol 179: 276–286.
7.
Ohyama, K., C. Farquharson, C.C. Whitehead, I.M. Shapiro (1997) Further observations on programmed cell death in the epiphyseal growth plate: comparison of normal and dyschondroplastic epiphyses. J Bone Miner Res 12: 1647–1656.
8.
Pucci, B., C.S. Adams, J. Fertala, B.C. Snyder, K.D. Mansfield, M. Tafani, T. Freeman, I.M. Shapiro (2007) Development of the terminally differentiated state sensitizes epiphyseal chondrocytes to apoptosis through caspase-3 activation. J Cell Physiol 210: 609–615.
9.
Schwartz, Z., D.H. Carney, R.S. Crowther, J.T. Ryaby, B.D. Boyan (2005) Thrombin peptide (TP508) treatment of rat growth plate cartilage cells promotes proliferation and retention of the chondrocytic phenotype while blocking terminal endochondral differentiation. J Cell Physiol 202: 336–343.
10.
Sheller, M.R., R.S. Crowther, J.H. Kinney, J. Yang, S. Di Jorio, T. Breunig, D.H. Carney, J.T. Ryaby (2004) Repair of rabbit segmental defects with the thrombin peptide, TP508. J Orthop Res 22: 1094–1099.
11.
Simmons, D.J., J. Yang, S. Yang (1998) Acceleration of rat femoral fracture healing by a synthetic thrombin peptide; in Dacke, C., J. Danks, G. Flik, C. Gay (eds): Calcium Metabolism. Bristol, BioScientifica Ltd., pp 145–152.
12.
Teixeira, C.C., K. Mansfield, C. Hertkorn, H. Ischiropoulos, I.M. Shapiro (2001) Phosphate-induced chondrocyte apoptosis is linked to nitric oxide generation. Am J Physiol Cell Physiol 281: C833–C839.
13.
Vortkamp, A., S. Pathi, G.M. Peretti, E.M. Caruso, D.J. Zaleske, C.J. Tabin (1998) Recapitulation of signals regulating embryonic bone formation during postnatal growth and in fracture repair. Mech Dev 71: 65–76.
14.
Zhong, M., L.J. Wike, J.T. Ryaby, D.H. Carney, B.D. Boyan, Z. Schwartz (2008) Thrombin peptide TP508 prevents nitric oxide mediated apoptosis in chondrocytes in endochondral development pathway. Biochim Biophys Acta 1783: 12–22.
© 2008 S. Karger AG, Basel
2008
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.